SOUTH SAN FRANCISCO, Calif., Feb. 19, 2010 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, will report fourth quarter and fiscal year-end 2009 results, along with guidance for 2010, on Thursday, February 25, 2010 . A conference call and webcast hosted by OXiGENE management will begin at 4:30 pm EST (1:30 p.m. PST).
